PUNITIVE DAMAGES OFFER LITTLE "ADDITIONAL INCENTIVE"
This article was originally published in The Tan Sheet
Executive Summary
PUNITIVE DAMAGES OFFER LITTLE "ADDITIONAL INCENTIVE" for drug manufacturers to protect the safety of consumers, Pharmaceutical Manufacturers Association representative Richard Cooper maintained during a March 15 hearing before Sen. Howell Heflin's (D-Ala.) Judiciary/courts and administrative practice subcommittee hearing on pending legislation (S 687). Cooper stated that "the additional incentive that would be provided by punitive damages would be extremely small and probably outweighed by the general cost of punitive damages to the health care system."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning